A new drug, called pritelivir, may offer a new treatment option for patients with genital herpes, a new industry-sponsored – study led by University of Washington researchers has found.
Tag: Anna Wald
The vaccine is the first to significantly reduce the frequency of viral shedding — the surfacing of herpes virus on the genitals — and appears to activate T cell immune responses to the virus.